DK0788790T3 - Farmaceutisk tablet, der er egnet til afgivelse af det aktive stof på efterfölgende og forudbestemmelige tidspunkter - Google Patents

Farmaceutisk tablet, der er egnet til afgivelse af det aktive stof på efterfölgende og forudbestemmelige tidspunkter

Info

Publication number
DK0788790T3
DK0788790T3 DK97101689T DK97101689T DK0788790T3 DK 0788790 T3 DK0788790 T3 DK 0788790T3 DK 97101689 T DK97101689 T DK 97101689T DK 97101689 T DK97101689 T DK 97101689T DK 0788790 T3 DK0788790 T3 DK 0788790T3
Authority
DK
Denmark
Prior art keywords
active substance
pharmaceutical tablet
delivery
subsequent
core
Prior art date
Application number
DK97101689T
Other languages
Danish (da)
English (en)
Inventor
Ubaldo Conte
Lauretta Maggi
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Application granted granted Critical
Publication of DK0788790T3 publication Critical patent/DK0788790T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
DK97101689T 1996-02-06 1997-02-04 Farmaceutisk tablet, der er egnet til afgivelse af det aktive stof på efterfölgende og forudbestemmelige tidspunkter DK0788790T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000210A IT1282576B1 (it) 1996-02-06 1996-02-06 Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili

Publications (1)

Publication Number Publication Date
DK0788790T3 true DK0788790T3 (da) 2004-09-20

Family

ID=11373151

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97101689T DK0788790T3 (da) 1996-02-06 1997-02-04 Farmaceutisk tablet, der er egnet til afgivelse af det aktive stof på efterfölgende og forudbestemmelige tidspunkter

Country Status (10)

Country Link
US (1) US6294200B1 (https=)
EP (1) EP0788790B1 (https=)
JP (1) JPH09221416A (https=)
AT (1) ATE267007T1 (https=)
AU (1) AU720914B2 (https=)
CA (1) CA2196840C (https=)
DE (1) DE69729134T2 (https=)
DK (1) DK0788790T3 (https=)
ES (1) ES2220999T3 (https=)
IT (1) IT1282576B1 (https=)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
IT1295271B1 (it) * 1997-10-03 1999-05-04 Chiesi Farma Spa Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
WO1999059552A1 (en) * 1998-05-15 1999-11-25 Chugai Seiyaku Kabushiki Kaisha Regulated release preparations
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
DE19927688A1 (de) * 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
DE19954421A1 (de) * 1999-11-12 2001-05-31 Lohmann Therapie Syst Lts Filmförmige Zubereitung zur biphasigen Freisetzung pharmakologisch wirksamer oder anderer Substanzen
WO2001055293A2 (en) * 2000-01-25 2001-08-02 The Victoria University Of Manchester Delayed release of fluids
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
BR0115585A (pt) 2000-11-28 2005-12-13 Fmc Corp Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
AU2008255254B2 (en) * 2001-03-31 2010-12-09 Jagotec Ag A pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance and respective processes of producing same and a cup-shaped envelope of same
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20040137062A1 (en) * 2001-05-25 2004-07-15 Sham Chopra Chronotherapy tablet and methods related thereto
IL159812A0 (en) * 2001-07-12 2004-06-20 Teva Pharma Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester in a controlled release core
IL159813A0 (en) * 2001-07-12 2004-06-20 Teva Pharma Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
NZ532096A (en) * 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US20040146559A1 (en) * 2002-09-28 2004-07-29 Sowden Harry S. Dosage forms having an inner core and outer shell with different shapes
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7126786B1 (en) * 2001-10-01 2006-10-24 Certance Llc Motor/encoder assembly for tape drives
AU2002346372A1 (en) * 2001-11-13 2003-05-26 Teva Pharmaceutical Industries, Ltd. Process for the production of l-dopa ethyl ester
WO2003041646A2 (en) 2001-11-13 2003-05-22 Teva Pharmaceutical Industries, Ltd. L-dopa ethyl ester salts and uses thereof
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
US20060013875A1 (en) * 2002-05-29 2006-01-19 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20040166159A1 (en) * 2002-05-29 2004-08-26 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
PL193976B1 (pl) * 2002-07-01 2007-04-30 Pliva Krakow Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20040081695A1 (en) * 2002-09-28 2004-04-29 Sowden Harry S Dosage forms having an inner core and an outer shell
AU2003220472A1 (en) * 2002-09-28 2004-04-19 Mcneil-Ppc, Inc. Modified release dosage form with two cores
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US8163306B2 (en) * 2003-09-19 2012-04-24 Sun Pharma Advanced Research Company Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
CA2549195A1 (en) * 2003-12-09 2005-06-23 Spherics, Inc. Bioadhesive polymers with catechol functionality
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
WO2005107811A2 (en) * 2004-05-04 2005-11-17 Perry Victor A Drug delivery device
US7780985B2 (en) * 2005-07-12 2010-08-24 Accu-Break Technologies, Inc. Tablets having a printed separation mark to guide breaking
US7622137B2 (en) * 2004-05-21 2009-11-24 Accu-Break Technologies, Inc. Dosage forms contained within a capsule or sachet
US7713547B2 (en) 2004-05-21 2010-05-11 Accu-Break Pharmaceuticals, Inc. Method of administering a partial dose of a segmented pharmaceutical tablet
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
AU2005245025B2 (en) * 2004-05-21 2010-06-03 Accu-Break Technologies, Inc. Pharmaceutical tablets comprising two or more unitary segments
US7838031B2 (en) 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US7329418B2 (en) * 2004-05-21 2008-02-12 Accu Break Technologies, Inc. Pharmaceutical tablets having height greater than width
US20060002986A1 (en) * 2004-06-09 2006-01-05 Smithkline Beecham Corporation Pharmaceutical product
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
AU2005281797B2 (en) * 2004-09-10 2011-07-07 Jagotec Ag Tablets with site and time-controlled gastrointestinal release of active ingredient
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
US8022032B2 (en) 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
CA2613631A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Improved dosage forms for movement disorder treatment
KR100714616B1 (ko) * 2005-06-23 2007-05-07 삼성전기주식회사 지수 함수 발생기 및 이를 이용한 가변 이득 증폭기
WO2007008305A1 (en) 2005-07-08 2007-01-18 Cherng-Ju Kim Asymmetrically coated tablet
EP1948138A4 (en) * 2005-11-18 2012-07-11 Accu Break Technologies Inc SEGMENTED PHARMACEUTICAL DOSAGE FORMS
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
EP2086515A2 (en) * 2006-03-02 2009-08-12 Vaunnex, Inc. Rate-controlled bioadhesive oral dosage formulations
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
AU2007268240B2 (en) * 2006-05-23 2012-12-06 Orahealth Corporation Xylitol troches and methods of use
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
SI2049123T1 (sl) 2006-08-03 2013-04-30 Horizon Pharma Ag Zdravljenje revmatoznih bolezni z zadržanim sproščanjem glukokortikoida
WO2008021875A2 (en) * 2006-08-08 2008-02-21 Accu-Break Technologies, Inc. Pharmaceutical tablets containing a plurality of active segments
CA2662123C (en) * 2006-08-30 2015-12-01 Jagotec Ag Controlled release oral dosage formulations comprising a core and one or more barrier layers
AU2007338631A1 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
US20110020408A1 (en) * 2007-05-17 2011-01-27 Ranbaxy Laboratories Limited multilayered modified release formulation comprising amoxicillin and clavulanate
US8513323B2 (en) * 2007-06-22 2013-08-20 Kimbery-Clark Worldwide, Inc. Multifunctional silicone blends
AU2008286914B2 (en) * 2007-08-13 2014-10-02 Ohemo Life Sciences Inc. Abuse resistant drugs, method of use and method of making
CN101910113A (zh) 2007-12-28 2010-12-08 怡百克制药公司 左旋多巴控释制剂及其用途
CN102026628A (zh) * 2008-02-15 2011-04-20 太阳医药高级研发有限公司 具有降低崩裂效果的口服控释片剂
CN102202656A (zh) * 2008-08-15 2011-09-28 蒂宝制药公司 治疗和预防cns障碍的胃滞留药用组合物
WO2010085623A1 (en) 2009-01-22 2010-07-29 Cadbury Adams Usa, Llc Confectionery processing
JP5547291B2 (ja) * 2009-10-08 2014-07-09 インターコンチネンタル グレート ブランズ エルエルシー 共押出しされた層状キャンディーおよびガムの装置および方法
WO2011071877A2 (en) * 2009-12-07 2011-06-16 Mcneil-Ppc, Inc. Partial dip coating of dosage forms for modified release
US10485770B2 (en) 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
JPWO2011118453A1 (ja) * 2010-03-23 2013-07-04 リンテック株式会社 固形製剤
EP3049069A1 (en) * 2013-09-27 2016-08-03 Johnson & Johnson Consumer Inc. Compression coated pulsatile release compositions
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
CN105658211A (zh) 2013-10-07 2016-06-08 怡百克制药公司 左旋多巴和/或左旋多巴的酯的粘膜粘附性、控制释放调配物和其用途
CN103948557A (zh) * 2014-04-08 2014-07-30 闻晓光 一种新型控释片
AU2016272089B2 (en) 2015-06-03 2021-02-18 Triastek, Inc. Dosage forms and use thereof
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
EP3573602A4 (en) * 2017-01-26 2020-09-16 Triastek, Inc. DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES
JP7040418B2 (ja) * 2018-11-21 2022-03-23 株式会社村田製作所 錠剤
EP3788884A1 (de) * 2019-09-05 2021-03-10 Delica AG Kompostierbare kapsel sowie deren herstellung und verwendung
WO2022044045A1 (en) * 2020-08-26 2022-03-03 Rubicon Research Private Limited Modified release formulations of levodopa
CN114177155B (zh) * 2020-09-08 2023-10-03 越洋医药开发(广州)有限公司 一种布洛芬控释片及其制备方法
KR20230124622A (ko) 2020-12-22 2023-08-25 암닐 파마슈티컬스 엘엘씨 레보도파 투여 요법
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen
EP4702975A1 (en) * 2024-09-03 2026-03-04 Biotecnica Di Magagnini Mattia E Malatini Silvia Snc Stp Nutraceutical composition for the treatment of cystitis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1022171A (en) 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
FR2100858B1 (https=) 1970-07-03 1975-06-06 Daiichi Seiyaku Co
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
JP3725542B2 (ja) * 1993-10-19 2005-12-14 大正製薬株式会社 ピコサルフェート剤形

Also Published As

Publication number Publication date
IT1282576B1 (it) 1998-03-31
AU720914B2 (en) 2000-06-15
EP0788790A2 (en) 1997-08-13
EP0788790A3 (en) 1998-11-04
ATE267007T1 (de) 2004-06-15
AU1252697A (en) 1997-08-28
DE69729134D1 (de) 2004-06-24
CA2196840C (en) 2001-12-04
CA2196840A1 (en) 1997-08-07
US6294200B1 (en) 2001-09-25
EP0788790B1 (en) 2004-05-19
JPH09221416A (ja) 1997-08-26
ITMI960210A0 (https=) 1996-02-06
ITMI960210A1 (it) 1997-08-06
ES2220999T3 (es) 2004-12-16
DE69729134T2 (de) 2005-05-12

Similar Documents

Publication Publication Date Title
DK0788790T3 (da) Farmaceutisk tablet, der er egnet til afgivelse af det aktive stof på efterfölgende og forudbestemmelige tidspunkter
FI900740A0 (fi) Foerfarande foer framstaellning av ett terapeutiskt system foer administration av laekemedel genom huden och slemhinnorna och anvaendning av systemet.
DE69524436D1 (de) Verbesserte transdermale vorrichtung mit verringerter delaminierung
WO1992002212A3 (en) Use of interfacially-polymerized membranes in delivery devices
PL376776A1 (pl) Dozownik do regulowanego uwalniania substancji lotnych
DE69420087D1 (de) Pharmazeutische Tablette geeignet zur gestuften Freisetzung von Wirkstoffen
WO2002045700A3 (de) Absorptionsmittel und kanalbilder enthaltende wirkstoffundurcchlässige deckschicht oder abziehbare schutzschicht eines transdermalen therapeutischen systems
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
DE69428862D1 (de) Linsenförmig pharmazeutische Tablette mit verzögerter Freigabe
SE9102072L (sv) Oral, fast, farmaceutisk doseringsform med styrd frisaettning
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
YU49490A (sh) Postupak za izradu flastera kao transdermalnog sistema za davanje aktivnih materija na koži sa odavanjem aktivne materije kao i primena
NO884892D0 (no) Fremgangsmaate til innkapsling eller omdanning til fast stoff av et materiale med vandig kontinuerlig fase.
NO913296L (no) Sammensatte folie- og platematerialer med et topplag av hoeymolekylert polyetylen, samt fremgangsmaate for fremstilling av slike.
WO2003085698A3 (en) Encapsulated organic semiconductor device and method
ES2170245T3 (es) Metodo para la fabricacion de comprimidos estratificados para la liberacion controlada de principios activos.
DK0806202T3 (da) Farmaceutisk sammensætning på basis af stabiliserede, lipofile matricer til kontrolleret frigivelse af aktive stoffer
DK0551292T3 (da) Farmaceutiske præparater til reguleret frigivelse med overtrukken sidekant
TWI255724B (en) Preparation containing active and/or auxiliary substances, with controllable release of said substances, as well as its manufacture
NO910688D0 (no) Selvsperrende glidelaas for skjoeting av betongpeler.
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
ECSP982533A (es) Dispositivo para el suministro de plaguicidas agricolas
IT213760Z2 (it) Gruppo spalmatore di collante, per macchine taglia ribobinatrici e/o simili.